Thyroid dysfunction during treatment with systemic antineoplastic therapy for childhood cancer

Chantal A. Lebbink, Eef G. WM Lentjes, Wim J. E. Tissing, Marry M. van den Heuvel-Eibrink, Hanneke M. van Santen, Elvira C. van Dalen

Research output: Contribution to journalArticleAcademicpeer-review


Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To gain insight into the occurrence of and risk factors for aberrant thyroid function parameters (i.e. TSH, free thyroxine (FT4)) as expression of hypothyroidism, hyperthyroidism, or NTI during cancer treatment in children treated with systemic antineoplastic therapy.
Original languageEnglish
Article numberCD013805
JournalCochrane Database of Systematic Reviews
Issue number12
Publication statusPublished - 14 Dec 2020

Cite this